ArticleOncotarget2017

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.

Matteo Ferro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.